However, potent cytotoxic NKG2C+ NK cells can eliminate these autoreactive immune cells via recognition of surface HLA-E on activated, autoreactive B cells, CD8+ T cells, and CD4+ T cells, thereby potentially providing, to some extent, protection against MS. Here, KLRC2 is linked to myeloid sarcoma.